A pilot study to assess the tolerability and the effectiveness of combination treatment of olanzapine and escitalpram for bipolar depression in Japan
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2018
Price : $35 *
At a glance
- Drugs Escitalopram (Primary) ; Olanzapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms OLE-BD
- 28 Aug 2018 Status changed from recruiting to completed.
- 23 Sep 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 11 Jul 2014 New trial record